会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Negative pressure filtration device
    • 负压过滤装置
    • US5096474A
    • 1992-03-17
    • US448081
    • 1989-12-13
    • Joseph C. Miller, Jr.Garth S. Jones
    • Joseph C. Miller, Jr.Garth S. Jones
    • B08B15/02
    • B08B15/026
    • A negative pressure filtration device is used in conjunction with a containment enclosure for the removal of hazardous material such as asbestos insulation surrounding pipes in habitable buildings. The inventive negative pressure filtration device generates a negative pressure within the containment enclosure, which negative pressure is quantitatively adjustable and capable of being continuously monitored by the user. Advantageously, the negative pressure filtration device is small, lightweight, portable, battery-operated and reliable, for use in a wide variety of hazardous material removal scenarios. The portability and versatility of the negative pressure filtration device is achieved through the use of operational vacuum pressures and air flow volumes much smaller than those of known systems.
    • 负压过滤装置与容纳外壳结合使用,用于去除有害材料,例如居住建筑物中围绕管道的石棉绝缘。 本发明的负压过滤装置在容纳外壳内产生负压,该负压是可定量调节的并且能够由使用者持续监控。 有利地,负压过滤装置体积小,重量轻,便携,电池供电和可靠,用于各种有害物质去除情况。 负压过滤装置的便携性和多功能性通过使用比已知系统小得多的操作真空压力和空气流量来实现。
    • 4. 发明授权
    • Circuit for overriding the cripple mode so that the relay remains latched
    • 用于覆盖跛行模式的电路,以使继电器保持锁定
    • US5418679A
    • 1995-05-23
    • US43329
    • 1993-04-06
    • Burke J. CraneGarth S. JonesKevin L. Nelson
    • Burke J. CraneGarth S. JonesKevin L. Nelson
    • H01R13/703H02H3/12H02J13/00H02P7/00
    • H02J13/0079H02H3/12H02J13/0058H01H2300/03H01R13/7038Y02B70/3241Y02B90/224Y02B90/226Y04S20/14Y04S20/16Y04S20/227
    • A plug presence sensor comprises an LED and a light sensor in the form of a photo-transistor which senses presence of a plug in a receptacle. The sensor is monitored by a microcontroller to control latching of a relay. The microcontroller de-energizes the relay, so that no power is present at the receptacle, when no plug is inserted. When the plug is inserted, then the microcontroller causes the relay to be energized to provide power to the receptacle. The microcontroller is preprogrammed to communicate with a remote master controller. In the event that a loss of communication occurs between the microcontroller and the master controller, the microcontroller automatically de-energizes the relay so that no power is present at the receptacle. A communication error output signal is connected to an override circuit including a capacitor which differentiates an edge of the communication error signal to inject a pulse onto the plug presence sensor signal which simulates removal and reinsertion of the plug. As such, the override circuit fools the microcontroller into thinking that a plug was removed and then inserted so that the relay remains energized to power the outlet receptacle.
    • 插头存在传感器包括LED和光电晶体管形式的光传感器,其感测插头在插座中的存在。 传感器由微控制器监控以控制继电器的锁存。 微控制器使继电器断电,当插头没有插头时,插座上没有电源。 当插头插入时,微控制器使继电器通电以向插座供电。 微控制器被预编程以与远程主控制器进行通信。 在微控制器和主控制器之间发生通信损失的情况下,微控制器自动断开继电器的电源,使得插座上没有电源。 通信错误输出信号连接到包括电容器的超控电路,该电容器区分通信误差信号的边沿以将脉冲注入到模拟插头的去除和重新插入的插头存在传感器信号上。 因此,超控电路愚弄微控制器,认为插头被移除然后被插入,使得继电器保持通电以为插座提供动力。
    • 8. 发明授权
    • Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
    • 腺苷环缩酮:用于药物治疗的新型腺苷类似物
    • US06995148B2
    • 2006-02-07
    • US09828276
    • 2001-04-05
    • Garth S. JonesEdwin K. Jackson
    • Garth S. JonesEdwin K. Jackson
    • C07D473/34C07D471/04A61K31/52
    • C07D473/00A61K31/52A61K31/7076C07H19/16
    • The present invention relates to novel compounds that are novel adenosine receptor analogues. Specifically, the compounds of the present invention preferably function as both adenosine receptor agonists and ganglionic blocking agents. To achieve this functionality, the compounds of the present invention, preferably contain a ganglionic blocking motif, is inserted into the adenosine molecule. The ganglionic blocking motif preferably includes an elongated carbon chain that, in a particularly preferred embodiment, contains two terminal amino groups. The ganglionic blocking motif preferably includes a carbon along the elongated carbon chain that is integral to a cyclic ketal that is part of the adenosine molecule. In presently-preferred embodiments, the elongated carbon chain ranges from two to sixteen carbons in length. The compounds of the present invention will be useful for treatment of a variety of conditions including, but not limited to, hypertension, vasodilation, and ischemia.
    • 本发明涉及新型的腺苷受体类似物的化合物。 具体地说,本发明的化合物优选用作腺苷受体激动剂和神经节阻滞剂。 为了实现这一功能,将本发明的化合物优选含有神经节阻断基序插入到腺苷分子中。 神经节阻断基序优选包括细长碳链,其在特别优选的实施方案中包含两个末端氨基。 神经节阻断基序优选包括沿着作为腺苷分子一部分的环状缩酮整合的细长碳链的碳。 在目前优选的实施方案中,细长碳链长度为2至16个碳。 本发明的化合物可用于治疗各种病症,包括但不限于高血压,血管舒张和缺血。